Elisabetta Piscitelli

Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status

F. Galluzzi, Stefano Stagi, Roberto Salti et al. · European Journal of Endocrinology · 2005 · 79 citations

Medicine, Endocrinology, Pediatrics +17

A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells

Adriana Lombardi, Giulia Cantini, Elisabetta Piscitelli et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 71 citations

Life Sciences, Immunology, Pharmacology +17

Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF‐IR Intracellular Signaling

Giulia Cantini, Adriana Lombardi, Elisabetta Piscitelli et al. · PPAR Research · 2008 · 50 citations · Full text

Medicine, Oncology, Pharmacology +14

Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?

Laura Masi, Gabriele Simonini, Elisabetta Piscitelli et al. · PubMed · 2004 · 48 citations

Medicine, Immunology, Bone Metabolism +16

Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients

Anna Maria Carossino, Raffaella Recenti, Roberto Carossino et al. · Biogerontology · 2007 · 21 citations

Engineering, Bioengineering, Cell Biology +17